The DHA chose to implement Omnicell's Robomat robotic dispensing
system—consisting of the Medimat storage and dispensing unit and the
Speedbox filling system—in order to achieve maximum automation with
minimal manual input and provide quicker, safer, and more efficient
dispensing. The Omnicell technology will help speed up the process to
prescribe medicine to patients, and increase accuracy in measuring,
leading to greater patient satisfaction.
The robotic dispensing
systems will not only reduce customer waiting time but enable the
pharmacist to spend more time with patients to give detailed
instructions and information regarding their medications.
"Implementing
the Omnicell robotic dispensing solution is an important step in
significantly decreasing the patient waiting time and increasing the
efficiency of the outpatient pharmacy to provide our patients with an
excellent healthcare service. This is in line with our mission to
develop an integrated and sustainable healthcare system that helps
ensure the delivery of comprehensive and excellent services," said Dr. Ali Al Sayed Hussain,
director, Pharmacy Department with the Dubai Health Authority. "We look
forward to further cooperation with Omnicell and introducing automation
solutions in the inpatient department to achieve the highest
international standards in the health of individuals and the community."
"We
are pleased that the Dubai Health Authority chose to implement
Omnicell's robotic dispensing systems to improve safety and patient
satisfaction within their network," said Baha El Mahgoub, general manager, Central & Eastern Europe
at Omnicell. "We look forward to expanding our partnership with
additional technologies to help them provide the highest standards of
care."
About Dubai Health Authority
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement. His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai
and UAE Minister of Finance is the President of the Dubai Health
Authority and His Excellency Humaid Mohammed Obaid Al Qatami is the
chairman of the board of the Dubai Health Authority.
The DHA's aim in Dubai
is to provide an accessible, effective and integrated healthcare
system, protect public health and improve the quality of life within the
Emirate. This is a direct translation of the objectives of the Dubai
Strategic Plan 2015 launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum.
Keeping the strategic plan in mind, the DHA's mission is to ensure
access to health services, maintain and improve the quality of these
services, improve the health status of nationals, residents and visitors
and oversee a dynamic, efficient and innovative health sector.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including hospitals (Latifa, Dubai,
Rashid and Hatta), specialty centres (e.g. the Dubai Diabetes Center)
and DHA primary health centres spread throughout the Emirate of Dubai.
The
main pillars of service delivery at DHA health facilities are quality,
efficiency, patients and staff. It is our aim to maintain and improve
the quality and efficiency of DHA health services. An important aspect
of the service delivery strategy is to focus on patients, their needs
and satisfaction as well as attract, retain, nurture and support
outstanding staff.
Prior to the establishment of the DHA, the
Department of Health and Medical Services (DOHMS), which was established
in 1973, was the functioning authority that almost exclusively focused
on health service delivery.
About Omnicell
Since
1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more
efficient ways to manage medications and supplies across all care
settings. As a leader in medication and supply dispensing automation,
central pharmacy automation, IV robotics, analytics software, and
medication adherence and packaging systems, Omnicell is focused on
improving care across the entire healthcare continuum—from the acute
care hospital setting, to post-acute skilled nursing and long-term care
facilities, to the patient's home.
Over 4,000 customers worldwide use Omnicell®
automation and analytics solutions to increase operational efficiency,
reduce medication errors, deliver actionable intelligence and improve
patient safety.
Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.
Recent
Omnicell acquisitions, including Ateb, add distinct capabilities,
particularly in central pharmacy, IV robotics, and pharmacy software,
creating the broadest medication management product portfolio in the
industry.
For more information about Omnicell, Inc. please visit www.omnicell.com.